| Pre-infection | Fiebig stages I–II | Fiebig stages III–V | Chronic | P valuea | ||
---|---|---|---|---|---|---|---|
Fiebig stages I–II | Fiebig stages III–V | Chronic | |||||
Number of participants | 70 | 60 | 15 | 33 | N/A | N/A | N/A |
Female, N (%) | 70 (100%) | 60 (100%) | 15 (100%) | 32 (97%) | 1.000 | 1.000 | 0.143 |
Age in years | 21.1 (19.8–22.1) | 21.2 (19.9–22.5) | 22.5 (20.8–23.7) | 22.9 (21.4–24.3) | 0.508 | 0.039 | < 0.001 |
Viral load (log10 copies/mL) | N/A | 4.20 (3.50–4.92) | 6.26 (4.88–7.20) | 3.60 (3.04–4.31) | N/A | N/A | N/A |
CD4+ T cell counts (cells/μL) | 891 (751–1047) | 763 (538–911) | 444 (367–553) | 599 (470–756) | < 0.001 | < 0.001 | < 0.001 |